menu ☰
menu ˟

Intensive ranibizumab treatment of AMD linked to vascular adverse events

30 Jul 2014
Intensity of intravitreal ranibizumab treatment for age-related macular degeneration may be linked to vascular adverse events, but not to an increased risk of mortality, according to researchers.The researchers conducted a meta-analysis of 11 randomi...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.